Upper Limb Functional Index
Launched by UNIVERSIDAD CATÓLICA SAN ANTONIO DE MURCIA · Feb 13, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on translating and validating a tool called the Upper Limb Functional Index into the Albanian language. This tool is designed to help assess how well people can use their arms and shoulders, especially in those who experience pain or have had injuries. By making this tool available in Albanian, the researchers hope to improve communication and care for Albanian-speaking patients dealing with upper limb issues.
To participate in this study, individuals aged 18 to 75 who are experiencing shoulder pain, arm pain, or related muscle discomfort may be eligible. However, those with certain serious conditions like tumors or neurological diseases will not be included. While the trial is not yet recruiting participants, once it begins, participants can expect to complete questionnaires that will help researchers understand their pain and function in daily activities. Overall, this study aims to better support the Albanian-speaking community in addressing upper limb challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • shoulder pain
- • arm pain
- • myofascial pain
- • muscular pain
- • trigger points
- • arthritis
- Exclusion Criteria:
- • tumor
- • metabolic disease
- • neurologic conditions
About Universidad Católica San Antonio De Murcia
Universidad Católica San Antonio de Murcia (UCAM) is a prominent academic institution in Spain, dedicated to advancing research and innovation in the healthcare sector. With a strong emphasis on interdisciplinary collaboration, UCAM sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. The university fosters a research-driven environment, leveraging its state-of-the-art facilities and expert faculty to conduct rigorous scientific investigations. UCAM is committed to upholding the highest ethical standards in clinical research, ensuring the safety and well-being of participants while contributing valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported